Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

John Williams, Ph.D.: Building Better Antibodies

April 20, 2018 | City of Hope

City of Hope researchers use novel technology to add new functionalities to already potent proteins.

City of Hope Physicians and Researchers Announce Breakthroughs at AACR 2018

April 19, 2018 | Leticia Marquez

City of Hope scientists and doctors presented their latest cancer research at the annual meeting of the American Association for Cancer Research at Chicago’s McCormick Place on April 14 to 18.

CAR T Laboratory Research Yields Promising Prostate Cancer Results

April 17, 2018 | Letisia Marquez

City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.

City of Hope Physician-in-Chief Named AACR Academy Fellow

April 13, 2018 | City of Hope

City of Hope President and Physician-in-Chief Michael A. Caligiuri, M.D., has been named a 2018 Fellow of the American Association for Cancer Research’s AACR Academy.

Kimlin Tam Ashing, Ph.D.: The Dangerous Effects of Racism on Health

April 10, 2018 | Saundra Young

It’s not new that research has linked stress to racial discrimination. But that research is now going a step further, tying infant mortality directly to racism. City of Hope's CCARE is already working with community health leaders to address the links between racism and poor health outcomes.

Four Things to Know About Head and Neck Cancers

April 3, 2018 | Tyler Stoudt

Cancers of the head and neck frighten patients, but there are new methodologies that should ease minds, according to City of Hope's Thomas Gernon, M.D.

Six Lessons from Behind the Scenes at City of Hope’s CAR T Cell Program

April 2, 2018 | Wayne Lewis

Often unrecognized are the countless folks who work in the spaces between the lab and the clinic — people responsible for doing everything from manufacturing CAR T cells to gaining federal approval for new trials.

What You Should Know About Multiple Myeloma

March 30, 2018 | Kevin Chesley

Multiple myeloma is a blood cancer involving malignant white blood (plasma) cells in the bone marrow. Most often affecting patients 65 and older, it is a debilitating malignancy.

Sound Therapy: TGen Tests Ultrasound to Enhance Cancer Drug Delivery

March 26, 2018 | City of Hope

City of Hope affiliate TGen has teamed up with a Norwegian biotech company to test the use of ultrasounds to direct and focus cancer drug therapies.

From Agriculture to Virology: The Accidental Vaccine Developer

March 23, 2018 | Katie Neith

With undergrad training in horticulture, a master’s degree in entomology and a Ph.D. in agriculture, Javier Gordon Ogembo, Ph.D., more or less stumbled into medicine — and the field is lucky to have him.

Load More